Direkt zum Inhalt
Merck
  • Repeated stimulation of dopamine D1-like receptor and hyperactivation of mTOR signaling lead to generalized seizures, altered dentate gyrus plasticity, and memory deficits.

Repeated stimulation of dopamine D1-like receptor and hyperactivation of mTOR signaling lead to generalized seizures, altered dentate gyrus plasticity, and memory deficits.

Hippocampus (2014-07-22)
Giuseppe Gangarossa, Laura Ceolin, Alexia Paucard, Mireille Lerner-Natoli, Julie Perroy, Laurent Fagni, Emmanuel Valjent
ZUSAMMENFASSUNG

The acute activation of the dopamine D1-like receptors (D1R) is involved in a plethora of functions ranging from increased locomotor activity to the facilitation of consolidation, storage, and retrieval of memories. Although much less characterized, epileptiform activities, usually triggered by disruption of the glutamate and GABA balance, have also been reported to involve the dopaminergic transmission. Using a combination of biochemical, immunohistochemical, electrophysiological, and behavioral approaches we have investigated the consequences of repeated stimulation of D1R using the selective D1R-like agonist SKF81297. Here, we report that repeated systemic administration of SKF81297 induces kindled seizures in mice. These seizure episodes parallel the hyperactivation of the mTOR signaling in the hippocampus, leading to disrupted long-term potentiation (LTP) in the dentate gyrus (DG) and altered recognition memories. The mTOR inhibitor rapamycin delays the development of SKF81297-induced kindled seizures, and rescues LTP in the DG and object recognition. Our results show that repeated stimulation of D1R is sufficient to induce generalized seizures leading to the overactivation of mTOR signaling, disrupted hippocampal plasticity, and impaired long-term recognition memories. This work highlights the interest of mTOR inhibitors as therapeutic strategies to reverse plasticity and cognitive deficits.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ethylenglycol, ReagentPlus®, ≥99%
Sigma-Aldrich
Natriumchlorid, Molecular Biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
Natriumchlorid -Lösung, 5 M in H2O, BioReagent, Molecular Biology, suitable for cell culture
Sigma-Aldrich
Natriumchlorid, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
Natriumchlorid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
Natriumchlorid -Lösung, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
Ethylenglycol, anhydrous, 99.8%
Sigma-Aldrich
Ethylenglycol, spectrophotometric grade, ≥99%
USP
Ethylenglycol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Natriumphosphat, 96%
Supelco
Ethylenglycol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Natriumchlorid -Lösung, 5 M
SAFC
Natriumchlorid -Lösung, 5 M
Sigma-Aldrich
Natriumchlorid, BioUltra, Molecular Biology, ≥99.5% (AT)
Sigma-Aldrich
1,4-Diazabicyclo[2.2.2]octan, ReagentPlus®, ≥99%
Sigma-Aldrich
Natriumchlorid, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
Natriumchlorid -Lösung, BioUltra, Molecular Biology, ~5 M in H2O
Sigma-Aldrich
Natriumchlorid, 99.999% trace metals basis
Sigma-Aldrich
Rapamycin, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Supelco
Natriumchlorid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Carbamazepin, powder
Sigma-Aldrich
Dabco® 33-LV
Supelco
Natriumchlorid, reference material for titrimetry, certified by BAM, >99.5%
Supelco
Ethylenglycol, analytical standard
Sigma-Aldrich
Ethylenglykol 5 M -Lösung
Sigma-Aldrich
Natriumchlorid -Lösung, 0.85%
Sigma-Aldrich
Natriumchlorid, BioPerformance Certified, ≥99% (titration), suitable for insect cell culture, suitable for plant cell culture
Supelco
Rapamycin, VETRANAL®, analytical standard
Sigma-Aldrich
Xylazin, ≥99%
Sigma-Aldrich
Natriumchlorid, tested according to Ph. Eur.